These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32932044)

  • 1. Triptolide-nanoliposome-APRPG, a novel sustained-release drug delivery system targeting vascular endothelial cells, enhances the inhibitory effects of triptolide on laser-induced choroidal neovascularization.
    Lai K; Li Y; Gong Y; Li L; Huang C; Xu F; Zhong X; Jin C
    Biomed Pharmacother; 2020 Nov; 131():110737. PubMed ID: 32932044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide attenuates laser-induced choroidal neovascularization via M2 macrophage in a mouse model.
    Lai K; Gong Y; Zhao W; Li L; Huang C; Xu F; Zhong X; Jin C
    Biomed Pharmacother; 2020 Sep; 129():110312. PubMed ID: 32559620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal injection of triptolide attenuates subretinal fibrosis in laser-induced murine model.
    Lai K; Li Y; Li L; Gong Y; Huang C; Zhang Y; Cheng L; Xu F; Zhao H; Li C; Zhong X; Jin C
    Phytomedicine; 2021 Dec; 93():153747. PubMed ID: 34620548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APRPG-modified nanoliposome loaded with miR-146a-5p inhibitor suppressed choroidal neovascularization by targeting endothelial cells.
    Li L; Lai K; Li C; Gong Y; Xu F; Zhao H; Zhou L; Huang C; Jin C
    Cutan Ocul Toxicol; 2020 Dec; 39(4):354-362. PubMed ID: 32928013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) inhibits experimental choroidal neovascularization in vivo and VEGF-induced cell migration and tube formation in vitro.
    Lai K; Xu L; Jin C; Wu K; Tian Z; Huang C; Zhong X; Ye H
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5702-12. PubMed ID: 21666238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide.
    Cai XJ; Fei WD; Xu YY; Xu H; Yang GY; Cao JW; Ni JJ; Wang Z
    Drug Deliv Transl Res; 2020 Feb; 10(1):93-107. PubMed ID: 31418132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of choroidal neovascularization by intravitreal injection of liposomal SU5416.
    Honda M; Asai T; Umemoto T; Araki Y; Oku N; Tanaka M
    Arch Ophthalmol; 2011 Mar; 129(3):317-21. PubMed ID: 21402988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice.
    Yamada K; Sakurai E; Itaya M; Yamasaki S; Ogura Y
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1839-43. PubMed ID: 17389519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
    Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
    Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney-targeted triptolide-encapsulated mesoscale nanoparticles for high-efficiency treatment of kidney injury.
    Deng X; Zeng T; Li J; Huang C; Yu M; Wang X; Tan L; Zhang M; Li A; Hu J
    Biomater Sci; 2019 Dec; 7(12):5312-5323. PubMed ID: 31617509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Cancer Angiogenesis Using Triptolide Nanoparticles.
    Wang C; Shan Y; Yang J; Xu X; Zhuang B; Fan Y; Xu W
    J Biomed Nanotechnol; 2015 May; 11(5):805-15. PubMed ID: 26349393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage depletion inhibits experimental choroidal neovascularization.
    Sakurai E; Anand A; Ambati BK; van Rooijen N; Ambati J
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3578-85. PubMed ID: 12882810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental choroidal neovascularization by curcumin in mice.
    Xie P; Zhang W; Yuan S; Chen Z; Yang Q; Yuan D; Wang F; Liu Q
    PLoS One; 2012; 7(12):e53329. PubMed ID: 23285282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation-Responsive Mesoporous Silica Nanoparticles with Synergistic Anti-inflammatory and Joint Protection Effects for Rheumatoid Arthritis Treatment.
    Wu YZ; Chen WY; Zeng Y; Ji QL; Yang Y; Guo XL; Wang X
    Pharm Res; 2024 Jul; 41(7):1493-1505. PubMed ID: 38918308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice.
    Koto T; Nagai N; Mochimaru H; Kurihara T; Izumi-Nagai K; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4328-34. PubMed ID: 17724224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
    Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin.
    Izumi-Nagai K; Nagai N; Ohgami K; Satofuka S; Ozawa Y; Tsubota K; Ohno S; Oike Y; Ishida S
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1679-85. PubMed ID: 18385091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
    Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
    Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
    Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.